Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)

Amir Qaseem, Jennifer Yost, Itziar Etxeandia-Ikobaltzeta, George M Abraham, Janet A Jokela, Mary Ann Forciea, Matthew C Miller, Linda L Humphrey

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish (US)
    Pages (from-to)673-679
    Number of pages7
    JournalAnnals of internal medicine
    Issue number5
    StatePublished - May 1 2021


    • COVID-19
    • severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
    • Pandemic
    • Coronavirus
    • Remdesivir

    ASJC Scopus subject areas

    • Internal Medicine

    Cite this